RANTES protein (ab87393)
Constituents: 10% Trehalose, 1.0X PBS
Our Abpromise guarantee covers the use of ab87393 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|SDS-PAGE||SDS-PAGE: Use at an assay dependent dilution.|
- Beta chemokine RANTES precursorCCL 5CCL5
- CCL5_HUMANChemokine (C C motif) ligand 5Chemokine CC Motif Ligand 5D17S136EEoCPEosinophil chemotactic cytokineMGC17164RANTES(4-68)Regulated upon activation normally T expressed and presumably secretedSCYA 5SCYA5SIS deltaSIS-deltaSISdSmall inducible cytokine A5Small inducible cytokine A5 (RANTES)Small inducible cytokine subfamily A (Cys Cys) member 5Small-inducible cytokine A5T cell specific protein p288T cell specific RANTES proteinT cell-specific protein P228T-cell-specific protein RANTESTCP 228TCP228
modificationsN-terminal processed form RANTES(3-68) is produced by proteolytic cleavage, probably by DPP4, after secretion from peripheral blood leukocytes and cultured sarcoma cells.
The identity of the O-linked saccharides at Ser-27 and Ser-28 are not reported in PubMed:1380064. They are assigned by similarity.
References for RANTES protein (ab87393)
ab87393 has not yet been referenced specifically in any publications.